MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$890M
Free Cash flow
$1,279M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Net increase (decrease) in comme...
Net income (loss)
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Payments for repurchase of commo...
Payments for investments and acq...
Payments for acquisitions of bus...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
904
1,339
670
755
Depreciation and amortization
355
351
365
342
Deferred and prepaid income taxes
17
-351
-22
69
Stock-based compensation expense
87
83
71
79
Goodwill and other intangible asset impairment charges
0
-
0
0
Net loss (gain) on investments and notes receivable
-12
158
-42
-10
Contingent consideration net expense (benefit)
-16
-30
7
11
Inventory step-up amortization
4
2
5
9
Fixed asset and right-of-use asset impairment
-
-
51
73
Other, net
36
27
20
-50
Trade accounts receivable
46
117
98
32
Inventories
133
177
50
94
Other assets
-19
109
-18
-5
Accounts payable, accrued expenses and other liabilities
234
-512
285
165
Cash provided by (used for) operating activities
1,474
348
1,364
1,343
Purchases of property, plant and equipment and internal use software
195
177
351
181
Payments for acquisitions of businesses, net of cash acquired
195
523
89
256
Proceeds from (payments for) investments and acquisitions of certain technologies
-
-61
74
70
Proceeds from sale of investments and dispositions of certain technologies
229
-
-
-
Proceeds for settlements of hedge contracts
-
-
-
0
Payments for investments and acquisitions of certain technologies
1,730
-
-
-
Other, net
5
-48
-73
-4
Cash provided by (used for) investing activities
-1,956
-591
-512
-502
Payment of contingent consideration previously established in purchase accounting
78
-
0
0
Payments for finance leases
0
0
209
7
Payments on short-term borrowings
13
259
0
12
Net increase (decrease) in commercial paper
1,675
0
0
-4
Proceeds from long-term borrowings, net of debt issuance costs
0
0
0
0
Cash used to net share settle employee equity awards
3
85
3
5
Payments for repurchase of common stock
2,000
-
-
-
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans
5
81
20
115
Other, net
5
3
9
-1
Cash provided by (used for) financing activities
-410
-260
-184
-104
Effect of foreign exchange rates on cash
1
0
3
-2
Net increase (decrease)in cash, cash equivalents, restricted cash and restricted cash equivalents
-890
-504
671
735
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period
1,643
2,147
919
919
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period
753
1,643
2,147
1,476
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$904M
(13.71%↑ Y/Y)
Depreciation and
amortization
$355M
(5.65%↑ Y/Y)
Accounts payable,
accrued expenses and...
$234M
(1.30%↑ Y/Y)
Stock-based compensation
expense
$87M
(16.00%↑ Y/Y)
Other, net
$36M
(-54.43%↓ Y/Y)
Other assets
-$19M
(-161.29%↓ Y/Y)
Deferred and prepaid
income taxes
$17M
(118.89%↑ Y/Y)
Net loss (gain) on
investments and notes...
-$12M
(-105.48%↓ Y/Y)
Inventory step-up
amortization
$4M
(-89.19%↓ Y/Y)
Cash provided by
(used for) operating...
$1,474M
(14.62%↑ Y/Y)
Effect of foreign
exchange rates on cash
$1M
(-50.00%↓ Y/Y)
Canceled cashflow
$195M
Net increase
(decrease)in cash, cash...
-$890M
(-397.21%↓ Y/Y)
Canceled cashflow
$1,475M
Proceeds from sale of
investments and...
$229M
Net increase
(decrease) in commercial...
$1,675M
Other, net
$5M
(600.00%↑ Y/Y)
Proceeds from issuances
of shares of common...
$5M
(-84.38%↓ Y/Y)
Inventories
$133M
(304.62%↑ Y/Y)
Trade accounts
receivable
$46M
(43.75%↑ Y/Y)
Contingent consideration
net expense...
-$16M
(-220.00%↓ Y/Y)
Cash provided by
(used for) investing...
-$1,956M
(-73.71%↓ Y/Y)
Canceled cashflow
$229M
Cash provided by
(used for) financing...
-$410M
(-20.59%↓ Y/Y)
Canceled cashflow
$1,685M
Payments for investments
and acquisitions of...
$1,730M
(5142.42%↑ Y/Y)
Payments for
acquisitions of businesses,...
$195M
(-80.67%↓ Y/Y)
Purchases of property,
plant and equipment...
$195M
(24.20%↑ Y/Y)
Other, net
$5M
(225.00%↑ Y/Y)
Payments for repurchase
of common stock
$2,000M
Payment of contingent
consideration previously...
$78M
(25.81%↑ Y/Y)
Payments on short-term
borrowings
$13M
(-97.40%↓ Y/Y)
Cash used to net share
settle employee equity...
$3M
(-40.00%↓ Y/Y)
Buy us a coffee
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)
Show more